Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.

Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.

Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.

Apple’s AI Doctor had better be one good virtual physician. 

Among the myriad processes to which AI could be meaningfully applied in healthcare, perhaps few are more easily overlooked than discharging patients from the hospital. 

The agency warned that any unused devices should be removed from the market and returned to the manufacturer.

Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.

Investors are betting on generative AI to solve costly provider workflow inefficiencies. So are provider executives.